Metabolic modulation of sympathetic vasoconstriction in exercising skeletal muscle

Acta Physiologica Scandinavica

Volumn 168, Issue 4, 2000, Pages 489-503

  Hansen, Jim ^a   Sander, M ^a   Thomas, G D ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alpha adrenoceptors; Exercise; Skeletal muscle blood flow; Skeletal muscle contraction; Skeletal muscle oxygenation; Sympathetic nervous system

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM ION;

ADRENERGIC SYSTEM; ARTERY CONSTRICTION; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; EXERCISE; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPEREMIA; INFRARED SPECTROSCOPY; MICROCIRCULATION; MUSCLE BLOOD FLOW; MUSCLE METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TRANSPORT; OXYGENATION; PRIORITY JOURNAL; SKELETAL MUSCLE; SYMPATHETIC NERVE; VASOCONSTRICTION;

ANIMALS; EXERCISE; EXERTION; HUMANS; MUSCLE, SKELETAL; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION;

EID: 0034036926     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2000.00701.x     Document Type: Conference Paper

References (57)

1. Alam, M. & Smirk, R.F. 1937. Observations in man upon a blood pressure raising reflex arising from the voluntary muscles. J Physiol 89, 372-383.
2. Balon, T.W. & Nadler, J.L. 1994. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77, 2519-2521.
3. Bolotina, V.M., Najibi, S., Palacino, J.J., Pagano, P.J. & Cohen, R.A. 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368, 850-853.
4. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K. & Bredt, D.S. 1995. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743-752.
5. van Brummelen, P., Jie, K., Timmermans, P.B. & van Zwieten, P.A. 1985. Postjunctional alpha-adrenoceptors and the regulation of arteriolar tone in humans. J Cardiovasc Pharmacol (Suppl 6), S149-S152.
6. van Brummelen, P., Jie, K. & van Zwieten, P.A. 1986. Alpha-adrenergic receptors in human blood vessels. Br J Clin Pharmacol 21 (Suppl 1), 33S-39S.
7. Chance, B. & Bank, W. 1995. Genetic disease of mitochondrial function evaluated by NMR and NIR spectroscopy of skeletal tissue. Biochimica et Biophysica Acta 1271, 7-14.
8. Chang, W.J., Iannaccone, S.T., Lau, K.S. et al. 1996. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci 93, 9142-9147.
9. Chavoshan, B., Sander, M. & Victor, R.G. 1997. Mechanisms of metabolic inhibition of sympathetic vasoconstriction in contracting human skeletal muscle: role of nitric oxide. Circulation 96, 1-70.
10. + channels in pancreatic β-cells. Nature (Lond) 311, 271-273.
11. Cornwell, T.L., Pryzwansky, K.B., Wyatt, T.A. & Lincoln, T.M. 1991. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol 40, 923-931.
12. Habler, H.-J., Wasner, G. & Janig, W. 1997. Attenuation of neurogenic vasoconstricion by nitric oxide in hindlimb microvascular beds of the rat in vivo. Hypertension 30, 957-961.
13. Hansen, J., Sayad, D., Thomas, G.D. et al. 1999. Exercise-induced attenuation of alpha-adrenoceptor mediated vasoconstriction in humans: evidence from phase-contrast MRI. Cardiovasc Res 41, 220-228.
14. Hansen, J., Thomas, G.D., Harris, S.A., Parsons, W.J. & Victor, R.G. 1996. Differential sympathetic neural control of oxygenation in resting and exercising humans skeletal muscle. J Clin Invest 98, 584-596.
15. Hansen, J., Thomas, G.D., Jacobsen, T.N. & Victor, R.G. 1994. Muscle metaboreflex triggers parallel sympathetic activation in exercising and resting human skeletal muscle. Am J Physiol 266 (6), H2508-H2514.
16. Hansen, J., Victor, R.G. & Mitchell, J.H. 1997. Control of regional sympathetic nerve activity during exercise: integration of studies in humans and animals. In: D. Jordan (ed.) Central Nervous Control of Autonomic Function, Vol. 11, pp. 189-223. Harwood, Amsterdam.
17. Kjellmer, I. 1965. On the competition between metabolic vasodilatation and neurogenic vasoconstriction in skeletal muscle. Acta Physiol Scand 63, 450-459.
18. Kobzik, L., Reid, M.B., Bredt, D.S. & Stamler, J.S. 1994. Nitric oxide in skeletal muscle. Nature 372, 546-548.
19. Koenig, M., Hoffman, E.P., Bertelson, C.J. et al. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517.
20. Krogh, A. & Lindhard, J. 1913. The regulation of respiration and circulation during the initial stages of muscular work, J Physiol 47, 112-136.
21. Lancaster, J.R.J. 1997. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1 (1), 18-13.
22. Laughlin, M.H., Korthuis, R.J., Duncker, D.J. & Bache, R.J. 1996. Control of blood flow to cardiac and skeletal muscle during exercise. In: L.B. Rowell & J.T. Shepherd (eds) Handbook of Physiology (Section 12). Exercise: Regulation and Integration of Multiple Systems, pp. 705-769. Oxford University Press, New York, Oxford.
23. Mancini, D.M., Bolinger, L., Li, H. et al. 1994. Validation of near infrared spectroscopy in humans. J Appl Physiol 77 (6), 2740-2747.
24. + channels, potassium, and muscle vasodilation in the rat in systemic hypoxia. J Physiol 472, 1-9.
25. McGillivray-Anderson, K.M. & Faber, J.E. 1990. Effect of acidosis on contraction of microvascular smooth muscle by alpha 1- and alpha 2-adrenoceptors. Implications for neural and metabolic regulation. Circ Res 66 (6), 1643-1657.
26. McGillivray-Anderson, K.M. & Faber, J.E. 1991a. Differential sensitivity of arteriolar alpha 1- and alpha 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circ Res 69 (1), 174-184.
27. McGillivray-Anderson, K.M. & Faber, J.E. 1991b. Effect of reduced blood flow on alpha 1- and alpha 2-adrenoceptor constriction of rat skeletal muscle microvessels. Circ Res 69 (1), 165-173.
28. 31P nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue. J Clin Invest 81, 1190-1196.
29. 2+ channels by alpha1A and alpha2A adrenoceptors in vascular myocytes: involvement of different transduction pathways. Cell Signal 7, 471-479.
30. Mitchell, J.H. & Schmidt, R.F. 1983. Cardiovascular reflex control by afferent fibers from skeletal muscle receptors. In: J.T. Shepherd & F.M. Abboud (eds) Handbook of Physiology. The Cardiovascular System. Part III, pp. 623-658. American Physiological Society, Bethesda, MD.
31. Murphy, M.E. & Brayden, J.E. 1995. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol 486, 47-58.
32. Nakane, M., Schmidt, H.H.H.W., Pollock, J.S., Forstermann, U. & Murad, F. 1993. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316, 175-180.
33. Nelson, M.T. & Quayle, J.M. 1995. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268 (37), C799-C822.
34. Nielsen, H., Hasenkam, J.M., Pilegaard, H.K., Mortensen, F.V. & Mulvany, M.J. 1991. Alpha-adrenoceptors in human resistance arteries from colon, pericardial fat, and skeletal muscle. Am J Physiol 261 (3 Part 2), H762-H767.
35. Nishimura, U. & van Breemen, C. 1989. Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun 163, 929-935.
36. O'Leary, D.S. 1991. Regional vascular resistance vs. conductance: which index for baroreflex responses? Am J Physiol 260 (2 Part 2), H632-H637.
37. Ohyanagi, M., Nishigaki, K. & Faber, J.E. 1992. Interaction between microvascular alpha 1- and alpha 2-adrenoceptors and endothelium-derived relaxing factor. Circ Res 71 (1), 188-200.
38. Patil, R.D., DiCarlo, S.E. & Collins, H.L. 1993. Acute exercise enhances nitric oxide modulation of vascular response to phenylephrine. Am J Physiol 265 (34), H1184-H1188.
39. Piantadosi, C.A. 1989. Near Infrared Spectroscopy: principles and application to noninvasive assessment of tissue oxygenation. J Crit Care 4 (4), 308-318.
40. Quast, U., Guillon, J.-M. & Cavero, I. 1994. Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 28, 805-810.
41. ATP channels in vascular smooth muscle. Cardiovasc Res 28, 797-804.
42. Rapaport, R.M. 1986. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidlyinositol hydrolysis in rat aorta. Circ Res 58, 407-410.
43. Rein, H. 1930. Die interferenz der vasomotorischen regulationen. Klin Wochenschr 9, 1485.
44. Rowell, L.B. 1993. Human Cardiovascular Control. Oxford University Press, New York.
45. Rowell, L.B., O'Leary, D.S. & Kellogg, D.L. 1996. Integration of cardiovascular control systems in dynamic exercise. In: L.B. Rowell & J.T. Shepherd (eds) Handbook of Physiology (Section 12). Exercise: Regulation and integration of Multiple Systems, pp. 770-840. Oxford University Press, New York, Oxford.
46. Rubanyi, G.M., Romero, J.C. & Vanhoutte, P.M. 1986. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250, H1145-H1149.
47. Saltin, B., Radegran, G., Koskolou, M.D. & Roach, R.C. 1998. Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand 162 (3), 421-436.
48. Sander, M., Chavoshan, B., Harris, S.A. et al. 1997. Functional sympatholysis is attenuated in neuronal nitric oxide synthase deficient skeletal muscle of boys with Duchenne muscular dystrophy. Circulation 96, 1-70.
49. Savard, G., Strange, S., Kiens, B. et al. 1987. Noradrenaline spillover during exercise in active versus resting skeletal muscle in man. Acta Physiol Scand 131 (4), 507-515.
50. Shepherd, J.T. 1987. Circulatory response to exercise in health. Circulation 76 (6 Part 2), VI3-10.
51. Tateishi, J. & Faber, J.E. 1995. ATP-sensitive K+ channels mediate alpha 2D-adrenergic receptor contraction of arteriolar smooth muscle and reversal of contraction by hypoxia. Circ Res 76 (1), 53-63.
52. Thomas, G.D., Hansen, J. & Victor, R.G. 1994. Inhibition alpha 2-adrenergic vasoconstriction during contraction glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol 266 (3 Part 2), H920-H929.
53. Thomas, G.D., Hansen, J. & Victor, R.G. 1997. ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99 (11), 2602-2609.
54. Thomas, G.D., Sander, M., Lau, K.S. et al. 1998. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle [see comments]. Proc Natl Acad Sci USA 95 (25), 15090-15095.
55. Thomas, G.D. & Victor, R.G. 1998. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol 506 (3), 817-826.
56. Wallin, B., Burke, D. & Gandevia, S. 1992. Coherence between the sympathetic drives to relaxed and contracting muscles of different limbs of human subjects. J Physiol 455, 219-233.
57. Wallin, B.G., Victor, R.G. & Mark, A.L. 1989. Sympathetic outflow to resting muscles during static handgrip and postcontraction muscle ischemia. Am J Physiol 256 (1), H105-H110.